parecoxib has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies
Studies (parecoxib) | Trials (parecoxib) | Recent Studies (post-2010) (parecoxib) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
---|---|---|---|---|---|
436 | 186 | 229 | 4,832 | 294 | 150 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bucher, M; Hobbhahn, J; Kees, FK; Lunz, D; Messmann, B; Rath, S; Schlitt, HJ; Zelenka, M | 1 |
1 trial(s) available for parecoxib and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Prostaglandin I2 release following mesenteric traction during abdominal surgery is mediated by cyclooxygenase-1.
Topics: 6-Ketoprostaglandin F1 alpha; Abdomen; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Epoprostenol; Female; Flushing; Heart Rate; Humans; Hypotension; Intraoperative Complications; Isoxazoles; Laparoscopy; Male; Middle Aged; Oxygen; Prospective Studies; Sulfonamides; Surgical Procedures, Operative; Tachycardia; Time Factors; Treatment Outcome | 2006 |